Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05945927 |
|---|---|
| Brief Title: | A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer |
| First Submitted : | June 29, 2023 |
| First Submitted that Met QC Criteria : | July 13, 2023 |
| First Posted : | July 14, 2023 |
| Last Update Submitted that Met QC Criteria : | May 22, 2024 |
| Last Update Posted : | May 23, 2024 |